2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on High-Risk HER2+ Early BC: Adjuvant T-DM1 + Pertuzumab vs. SoC - Did KAITLIN Study Demonstrate Improvement in IDFS?

128 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login